Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bottom at $106?
Can you elaborate it little more?
Pps is almost doubled in premarket with high volume: $48x 170k = $8 mil
Nice poster!
Nice story. I like the term you used - "market acceptance phase".
I don believe when posters say pps will stay where it is till we get trial data in 20xx.
Appreciate your contribution on the board.
GLTU
That’s very true. Their parents will even be able to tell if A273 works or not clearly.
Not a good analogy as each of them run AD clinical trial sites for 2-73 at their respective institutions.
They all hear,see and know the effects of A237 IMHO.
Thank you! You did it again.
This tells all: Beyond Amyloid -The sigma 1 receptor
And about 3 speakers including Dr.Missling, me think there are enough reasons to believe their appearances are related. : )
GLTU
yea the current holders believe in something but we don't see any other's big buys coming in
in spite of high level developments in GSE this year. PPS is same as in Feb.
If it were in 2012 with these kind news pps is probably @ $12 now. I saw $6 in 2012(not sure for year).
It wasn't diluted, was it? What changed, what am I not seeing?
Can not tell if you are serious or being sarcastic- hard to tell on this one. Lol
Ya really. Pps shows that people don't believe GSE reform.
Do we really expect an important announcement to release FNF any time now? Sigh........
I love the keyword you found- Promising!
I wondered why Dr. Hampel said "promising drug" last December.
Back then, it seemed too early for anyone to say "promising drug" for A273 in phase ll.
If your speculation is correct, company can not hold the news too long.
Maybe tomorrow ?
Thanks.
Really frustrating that is.....
No. But what do I know?
But the article was revised on 7/17/19 which is after 6/30/19 if I remember correct.
So it's still not clear. We'll see.
Why would the authors give Dr. M a chance to review the article before publishing?
The article wasn’t really for A273.
They mentioned A237 just in one sentence though it is a very strong statement. Too strong that it can not be an accident.
GLTA
And it is not related to AVXL. ha
I was too much focused on fast track issue today. Sorry, lol
Must be Australian talking about fast track for Alz trial?
I think someone mentioned it earlier today.
Below is news on Jul 2, 2018
https://www.9news.com.au/national/australian-dementia-network-launched-to-track-diagnosis-and-care-of-patients/8ebad8c0-1af1-4f8b-873a-686484a3c8ad
“ An Australian Dementia Network has been launched to monitor the diagnosis and care of thousands of patients across the country.
The Federal Government is injecting $38 million into the world-first program, which is hoped to fast-track treatment and research of the progressive disease.
A national registry will be launched, allowing those with dementia to participate in therapeutic trials. “
(edited)
I just realized they call "fast-track treatment".
Maybe it's different from what we were thinking? Not sure.
The article and link you quoted are dated in June 2016.
And they were for US orphan drug designation status in infantile spasms.
Adding more confusion.
Did you mean that authors of Nature were confused FT status with ODD status?
Now I don't think so as I see the quotation for ODD.
I don't see reasons for anyone to be confused with Alz and Children's spasm.
Crap. I sold $10000 of AVXL yesterday to put on a short term hot stock. : (
Yea but I don't care. Promising is what I care. lol
I remember that Dr. Harald Hampel used the word promising for A237 on his Face Book last December(?)
Yea it’s hard to believe Avxl got FT status without seeing a news by the company
but same time it’s hard to believe that is an error when a reason was attached for the status - because of promising result of phase ll.
Amazing!
GO AVXL!
I’m also surprised that MC from Rett side only is $2 billion.
It’s been discussed that MC for AZ is about $20 billion when Biogen lost around $20 billion for their failed Alzheimer drug if I remember correctly.
If $2 billion is for RS, shouldn’t MC for Alzheimer a lot bigger than $20 billion?
What Biogen lost is a dug not approved and stopped in the middle.
Wow I didn’t know AVXL is going to be that expensive - $200k/ year.
Thanks
Low volume. Shares to sell are dried up it seems. Good
Good find that we likely need. Thanks
Yea any number of reasons to hire or fire but....
What do you think Eisai saw in him when they hire Dr. HH?
If Eisai values HH, they would value what AVXL has too IMO.
I tried twice and couldn't find it.
Can you make those Australian videos more visible like other videos?
Thank you for your organizing vast info on one web page!
Maybe they are pressured not to publish by BP, I hope not.
Last year at AAIC or CTAD, I don’t remember which,on the website details of our presentation was mislabeled, berried with other’s presentation when Biogen was presenting their drug showed improvements. The one had side effect of brain swelling and its trial stopped.
The weather certainly got changed since the 60k share 2nd lowest volume day last Tuesday as you warned.
Not happy w/pps but I feel warm like in spa. Jump in people!
GLTA
bid, ask prices outside of trading hours are meaningless.
Brokerage firms remove them after market close and put them back before market open.
I thought you'd know it all.
Thanks.
It seems that some custodian players got stuck in, then.
Do you know what happened on 8-13? No selling or buying; no activities.
attilathehunt, Great! Thanks.
That will help in evaluating pps more accurately.
Outstanding shares increased about 25% past 2 years.
Pps should be reduced 20% for it.
AVXL is certainly undervalued without even considering other developments it has made.
Just saying....
Nuff said really.
Worthless.
It goes to 30.0 Definitely.
It will go to 300.0 it may need to split. Likely.
7% up right before the close of market yesterday
And give All back,even more, today.
I’ll never know what happened.
I used to be in here years ago.
So pps has been cut roughly 50%.
Shares must be around doubled you are saying.
Got ya. How much have shear count increased in past 2 years in percentage?
Thanks
A237 at 2.37. will buy lucky 237 shares at 2:37 today.
Feel very good. Oops it passed already.